Overview

Levofloxacin in Bacterial Rhinosinussitis

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Inflammatory paranasal diseases are among the most common diseases in ENT In Russia, puncture method has been conventional approach to treatment of maxillary sinusitis. However, this procedure is associated with a number of drawbacks A promising trend for the treatment of purulent sinusitis is a reasonable antibacterial therapy Fluoroquinolones, particularly levofloxacin, are highly active against pneumonocci and are more active vs. the drug products of the second generation against intracellular agents (Chlamydia spp., Mycoplasma spp., M. tuberculosis, rapidly growing atypical mycobacteria (M. avium, etc.). Due to high activity against the agents causing bacterial upper and lower respiratory tract infections they are sometimes called "respiratory" fluoroquinolones
Details
Lead Sponsor:
Dr. Reddy's Laboratories Limited
Treatments:
Amoxicillin
Amoxicillin-Potassium Clavulanate Combination
Clavulanic Acid
Clavulanic Acids
Ephedrine
Levofloxacin
Nasal Decongestants
Ofloxacin
Pseudoephedrine
Xylometazoline